Shady Grove Fertility and Reproductive Medicine Associates of New Jersey Announce Fertility Partners, a New Joint Venture to Support the Field of Reproductive Medicine
Leadership, innovation, expertise, and world-class reproductive care supports new collaborative venture
ROCKVILLE, Md. and BASKING RIDGE, N.J., Jan. 9, 2015 /PRNewswire-USNewswire/ -- Shady Grove Fertility (SGF) and Reproductive Medicine Associates of New Jersey (RMANJ) announced today a new joint venture, Fertility Partners, whose mission is to identify, develop, build, or enhance premier fertility and IVF centers of excellence across the nation. Dr. Richard T. Scott Jr., M.D., a founding partner of RMANJ commented, "We're very excited to collaborate with Shady Grove Fertility. Together we can offer members of Fertility Partners decades of combined experience, well-established and emerging technologies, plus several other market differentiators that can support their practices and their patients."
By combining the clinical, scientific, and commercial strengths of SGF and RMANJ, Fertility Partners is uniquely positioned to deliver value and growth to reproductive specialists. "This is an exceptional opportunity that provides a springboard for future, transformational development in the field of reproductive medicine," says Mark Segal, CEO of Fertility Partners and SGF. "We expect value, growth, and opportunity will naturally arise by connecting leading centers together in the spirit of collaboration," adds Segal.
Michael J. Levy, M.D., FACOG, Founding Partner and Director of IVF at SGF offered, "Fertility Partners intends to quickly connect practices and providers who share similar values and goals. SGF has been at the forefront of many advancements and services that have helped patients access care, like our Shared Risk Refund Program. Improving outcomes and offering patients the best possible fertility care experience is at the core of this exciting new venture."
"Our market faces many demographic and financial challenges. Yet both of our practices have grown more than 30 percent in the last 3 years, so we remain optimistic about the future. We're eager to share that growth recipe and that optimism through the Fertility Partners venture," commented Dr. Michael R. Drews, a founding partner of RMANJ.
"Fertility Partners intends to grow and expand the well-developed research, education, and advocacy programs already in place at SGF and RMANJ and to lead from strengths in all areas of reproductive medicine," said Eric A. Widra, M.D., Medical Director at SGF.
SGF and RMANJ will continue to operate independently while collaborating and developing the Fertility Partners venture. The two companies have signed a letter of intent and will provide additional details regarding the service structure of Fertility Partners in the coming weeks.
About Shady Grove Fertility
Shady Grove Fertility is a leading fertility and IVF center of excellence offering patients individualized care, innovative financial options, and pregnancy rates among the top 5 percent of all national centers. Since 1991, more than 37,000 babies have been born to patients from all 50 states and over 35 countries around the world. Shady Grove Fertility physicians actively invest in continuous clinical research and education to advance the field of reproductive medicine through numerous academic appointments and partnerships with Georgetown Medical School, Walter Reed, and the National Institutes of Health to train residents and reproductive endocrine fellows. Today, 32 reproductive endocrinologists, PhD scientists, geneticists, and more than 600 highly specialized Shady Grove Fertility staff care for patients in 18 full-service offices, and four satellite sites throughout Pennsylvania, Maryland, Virginia, and Washington, DC. For more information, call 1-888-761-1967 or visit www.ShadyGroveFertility.com
About Reproductive Medicine Associates of New Jersey
The experts at RMANJ have among the highest IVF delivery rates in the U.S. and pioneered a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that will lead to successful pregnancies and healthy deliveries. RMANJ is the only fertility center in the world to have developed a system of CCS with unprecedented accuracy that is fully validated through years of rigorous clinical research.
Since 1999, they have helped bring more than 30,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ (www.reifellowship.com), the practice has seven locations in New Jersey. For more information, call 973-656-2089 or visit www.rmanj.com.
SOURCE Fertility Partners
Share this article